Shikoku Kasei (4099) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Jul, 2026Executive summary
Net sales for Q1 2025 were ¥16,809 million, down 3.2% year-over-year.
Operating profit rose 26.3% year-over-year to ¥3,037 million.
Profit attributable to owners of parent increased 6.8% year-over-year to ¥1,925 million.
Comprehensive income declined 21.0% year-over-year to ¥2,372 million.
Financial highlights
Gross profit improved to ¥7,547 million from ¥6,869 million year-over-year.
Operating profit margin increased due to lower cost of sales and higher gross profit.
Basic earnings per share for Q1 2025 was ¥43.08, up from ¥36.72 in Q1 2024.
Total assets decreased to ¥127,995 million as of March 31, 2025, from ¥135,827 million at year-end 2024.
Net assets rose to ¥85,420 million, with a capital adequacy ratio of 66.1%.
Outlook and guidance
Full-year 2025 net sales forecast at ¥70,000 million, up 0.7% year-over-year.
Operating profit projected at ¥9,400 million, down 3.5% year-over-year.
Profit attributable to owners of parent expected to decline 26.2% to ¥6,500 million.
Annual dividend forecast maintained at ¥50.00 per share.
Latest events from Shikoku Kasei
- Record Q1 sales and profits, with upward full-year forecast after major overseas acquisition.4099
Q1 202613 Jul 2026 - Strong overseas Chemicals growth drove higher sales and profits, despite weaker Housing Materials.4099
Q3 202413 Jul 2026 - Record operating profit driven by fine chemicals, but housing materials segment underperformed.4099
Q3 202513 Jul 2026 - Record sales and profits led by Chemicals, but FY2025 profit expected to decline.4099
Q4 202413 Jul 2026 - Record sales and profit growth, global expansion via acquisition, and strong FY2026 outlook.4099
Q4 202513 Jul 2026 - Operating profit reached a record high despite lower sales, with strong fine chemicals performance.4099
Q2 202513 Jul 2026 - Record sales and profit growth led to upward revisions in full-year forecasts and dividends.4099
Q2 202413 Jul 2026